ERBB – A Sub-Penny Medical Marijuana Play that Could Explode

 

Dear valued subscribers,
 
As promised, I am (very) excited to bring you…
 
Tranzbyte Corporation (ERBB)

 
There are so many reasons why we love this company for a trade tomorrow. 
 
First, think ITNS (103% one day gain) and FITX (200% one day gain)… ERBB operates in the same super hot industry – Medical Marijuana – and is a similar priced play. On that fact alone with think ERBB is good for high double digit gains on Wednesday.

But it gets better…

ERBB just released some big time news after the bell Tuesday. 
 
The Company announced that they have formed The Altitude Organix Network. And a highly successful entrepreneur and businessman, Sean Loomer, has joined the team to oversea its roll out.
 
 
But what we really love is its chart… It is eerily similar to the chart of FITX before it exploded 200% in one day.
 

 
ERBB on the left, FITX on the right. They are almost identical (except we know how FITX turned out – 200% gains in one day!)
 
Now it’s ERBB‘s turn to excite. A more towards (and a break of) $0.007 could easily send ERBB towards its first resistance point of $0.018.
 
The power of the symmetrical triangle formation is huge. Combine that with a hot industry, positive news, and a lot of newsletter exposure and you get potential TRIPLE DIGIT GAINS!
 
ERBB is actually involved in some different businesses, but the Medical Marijuana business is what enthuses us, and it should you too.
 
Tranzbyte Corporation

Tranzbyte Corporation attracts established and early growth businesses seeking to take
advantage of resources not generally available to private companies through the
public capital markets and provides them mission-critical capital, legal,
accounting, and public relations resources. Tranzbyte then acquires these
companies and infuses them with the expertise and resources needed to transform
them into their own unique, fully-reporting, publicly-traded, bulletin board
companies. Following each spin out, Amergence uses its contacts and expertise
to assist each company’s introduction into the public marketplace.
 
The primary goal of the new business development enterprise (“BDE”) is to
coordinate services and activities intended to foster and promote a business
environment capable of accelerating the growth of these chosen innovative
companies. In exchange for its services, Tranzbyte accepts equity positions in
each of these promising new companies which are then divided between Amergence
and individual current ERBB shareholders following every spin-out.
 
 

For more information please visit www.tranzbyte.com

Altitude Organic Medicine
Altitude Organic Corporation is the first publicly traded medical marijuana dispensarybrand in the world. Beginning in 2009, the company has developed retailing, branding, and commercial cultivating strategies in conjunction with itslicensed medical marijuana retail dispensaries operating under the Altitude Organic Medicine brand name. The companyhas operated in California, Colorado, and Arizona. Altitude Organic Corporation is currently targeting expansion through dispensary and caregiver managedpartnerships, as well as outright acquisition in ‘for-profit’ medical marijuana states. The company seeks to capture market share in the fast growing,multi-billion dollar cannabis industry.

For more information please visit http://www.altitudeorganix.com
And our Conclusion…. Put ERBB on your radar immediately. It could be a very big mover Wednesday.
 
 
The Team
PennyStockGeneral.com
 
 

Click Below to Join Our Social Media Networks
 
     

————————————————————————————- DISCLAIMER —————————————————————————————

Never invest in any stock featured on our site or emails unless you can afford
to lose your entire investment.

Full disclaimer can be read at
http://pennystockgeneral.com/disclaimer-2/

Pennystockgeneral.com employees are not registered as an Investment Adviser in
any jurisdiction whatsoever.

The disclaimer is to be read and fully understood before using our site, or
joining our email list.

None of the materials or advertisements herein constitute offers or
solicitations to purchase or sell securities of the companies profiled herein
and any decision to invest in any such company or other financial decisions
should not be made based upon the information provide herein.  Instead pennystockgeneral.com strongly urges
you conduct a complete and independent investigation of the respective
companies and consideration of all pertinent risks. Pennystockgeneral.com does not offer such advice or analysis, and pennystockgeneral.com further urges
you to consult your own independent tax, business, financial and investment
advisors. Investing in micro-cap and growth securities is highly speculative
and carries and extremely high degree of risk. It is possible that an
investor’s investment may be lost or impaired due to the speculative nature of
the companies profiled.

Any statements that express or involve discussions with respect to predictions,
expectations, beliefs, plans, projections, objectives, goals, assumptions or
future events or performance are not statements of historical fact may be
“forward looking statements”. Forward looking statements are based on
expectations, estimates, and projections at the time the statements are made
that involve a number of risks and uncertainties which could cause actual
results or events to differ materially from those presently anticipated.
Forward looking statements in this action may be identified through use of
words such as “projects”, “foresee”, “expects”,
“will”, “anticipates”, “estimates”,
“believes”, “understands”, or that by statements indicating
certain actions “may”, “could”, or “might” occur.
Understand there is no guarantee past performance will be indicative of future
results.

In preparing this publication, pennystockgeneral.com has relied upon information supplied by its customers, and press releases whichit believes to be reliable; however, such reliability cannot be guaranteed.
Investors should not rely on the information contained in this website. Rather,
investors should use the information contained in this website as a starting
point for doing additional independent research on the featured companies. The
advertisements in this website are believed to be reliable, however, pennystockgeneral.com and its owners,
affiliates, subsidiaries, officers, directors, representatives and agents
disclaim any liability as to the completeness or accuracy of the information
contained in any advertisement and for any omissions of materials facts from
such advertisement. Pennystockgeneral.com
is not responsible for any claims made by the companies advertised herein.

Pennystockgeneral.com may receive compensation and its employees and affiliates may own stock that they
have purchased in the open market either prior, during, or after the release of
the companies profile which is an inherent conflict of interest in pennystockgeneral.com statements and
opinions and such statements and opinions cannot be considered independent. Pennystockgeneral.com and its
management may benefit from any increase in the share price of the profiled
companies and hold the right to sell the shares bought at any given time
including shortly after the release of the companies profile. PSG has been compensated three thousand dollars for this one day profileof ERBB.

Pennystockgeneral.com
may on occasion accept compensation in free-trading shares for it’s marketing
services of the company being profiled, and the third party that might have
compensated pennystockgeneral.com
may hold free-trading shares of the company being profiled and could very well
be selling shares of the companies stock at the same time the profile is being
disseminated to potential investors; this should be viewed as a definite
conflict of interest and as such, the reader should take this into
consideration.  If Pennystockgeneral.com
ever accepts compensation in the form of free trading shares of the company
being profiled and decides to sell these shares into the public market at any
time before, during, or after the release of the companies profile our
disclaimer will be updated accordingly reflecting the current position of those
free trading shares received as compensation for our services.
244 5th Ave, New York, NY 10001Unsubscribe | Change Subscriber Options